All In Biotech

Drug Trial Radar · NCT00921024

Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

A Multicenter, Double-blind, Randomized, Phase 2 Study to Compare the Safety and Efficacy of Intravenous CXA-101 and Intravenous Ceftazidime in Complicated Urinary Tract Infection, Including Pyelonephritis

Last checked: Nov 20, 2026Latest source record: Oct 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 129 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

129

Actual

Start

Jun 30, 2009

Primary completion

Feb 25, 2010

Study completion Mar 11, 2010

Sponsor

Sponsor type
Industry
First posted
Jun 16, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of intravenous CXA 101 and comparator in complicated urinary tract infection

Conditions

  • Complicated Urinary Tract Infection

Interventions

  • CXA-101Drug

    intravenous

  • CeftazidimeDrug

    intravenous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Microbiological Response at the Test of Cure (TOC) Visit in the Microbiological Modified Intent-to-Treat (mMITT) PopulationTime frame: TOC; 6-9 days after last study drug administration
  2. Microbiological Response at the TOC Visit in the Microbiologically Evaluable (ME) Population.Time frame: TOC; 6-9 days after last study drug administration

Locations

21 sites in 3 countries. Site status is shown where the registry gives one.

  • Healthcare Partners Medical Group

    Los Angeles, California

  • Compass Research, LLC

    Orlando, Florida

  • Atlanta Institute for Medical Research, Inc.

    Decatur, Georgia

  • Infectious Disease of Indiana, PSC

    Indianapolis, Indiana

  • Mississippi Medical Research, LLC

    Picayune, Mississippi

  • Great Falls Clinic, LLP

    Butte, Montana

  • Remington-Davis, Inc. Clinical Research

    Columbus, Ohio

  • Kreiskrankenhaus Backnang

    Backnang, Germany

  • URO Forschungs GmbH

    Berlin, Germany

  • Uniklinikum Giessen

    Giessen, Germany

  • Evangelisches Krankenhaus Giessen Urologie

    Giessen, Germany

  • Universitätsklinikum Schleswig Holstein Campus Lübeck

    Lübeck, Germany

  • Brüderkrankenhaus St. Josef Paderborn

    Paderborn, Germany

  • Urologische Klinik Dr. Castringius München-Planegg

    Planegg, Germany

  • Samodzielny Publiczny Szpital Kliniczny nr 4 Katedra i Klinika Nefrologii

    Lublin, Poland

  • Wojewódźki Szpital Specjalistyczny nr 1 Oddział Chorób Wewnętrznych

    Tychy, Poland

  • Szpital Bielański im.Ks. Jerzego Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej IV Kliniczny Oddzial Chorób Wewnętrznych

    Warsaw, Poland

  • Szpital Kliniczny Dzieciątka Jezus-Centrum Leczenia Obrażeń Klinika Urologii Ogólnej, Onkologicznej Czynnościowej

    Warsaw, Poland

  • Szpital Praski p.w. Przemienienia Pańskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej ll Oddział Wewnętrznych

    Warsaw, Poland

  • Wojewódźki Szpital Specjalistyczny Oddział Nefrologiczny

    Wroclaw, Poland

  • Samodzielny Publiczny Szpital Wojewódźki im. Papieża Jana Pawła ll Oddział Wewnętrznych Nefrologiczno-Endokrynologiczny ze Stacją Dializ

    Zamość, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.